Task: Answer the MCQ question.
Query: Which drug exhibits a 17.001\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) O=C1CNC(=S)N1C(CO)c1ccccc1
b) Cc1ccc(NC(=O)CN(C)C(=O)COc2ccc(C(=O)c3ccc(F)cc3)cc2)cc1
c) CCN1CCN(C(CNS(=O)(=O)c2ccc(Cl)cc2)c2cccnc2)CC1
Answer: a. O=C1CNC(=S)N1C(CO)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1CNC(=S)N1C(CO)c1ccccc1
O=C1CNC(=S)N1C(CO)c1ccccc1
3-(2-hydroxy-1-phenylethyl)-2-sulfanylideneimidazolidin-4-one